Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bart A. Nijmeijer
Observed names:
B A Nijmeijer,
B. A. Nijmeijer,
B. Nijmeijer,
Bart A Nijmeijer,
Bart Nijmeijer,
Nijmeijer, B.,
Nijmeijer, Bart
show all 7
Institution:
LinXis Biopharmaceuticals (Netherlands)
Observed institutions:
Leiden University Medical Center,
University Medical Center Utrecht,
LinXis Biopharmaceuticals (Netherlands),
UniQure (Netherlands)
OpenAlex ID:
A5089776151
Internalization and cell cycle-dependent killing of leukemic cells by Gemtuzumab Ozogamicin: rationale for efficacy in CD33-negative malignancies with endocytic capacity
2003
·
I Jedema
, R M Y Barge
, et al.
·
Leukemia
·
156
Therapeutic hFIX Activity Achieved after Single AAV5-hFIX Treatment in Hemophilia B Patients and NHPs with Pre-existing Anti-AAV5 NABs
2019
·
Anna Majowicz
, Bart Nijmeijer
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
132
PDF
Long–term culture of primary human lymphoblastic leukemia cells in the absence of serum or hematopoietic growth factors
2009
·
Bart A. Nijmeijer
, Karoly Szuhai
, et al.
·
Experimental Hematology
·
74
Differential Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway in Acute Lymphoblastic Leukemia
2013
·
Susanne Badura
, Tamara Tesanovic
, et al.
·
PLoS ONE
·
69
PDF
Imatinib mesylate at therapeutic doses has no impact on folliculogenesis or spermatogenesis in a leukaemic mouse model
2011
·
Beate Schultheis
, Bart A. Nijmeijer
, et al.
·
Leukemia Research
·
65
Optimization of viral protein ratios for production of rAAV serotype 5 in the baculovirus system
2018
·
Bas Bosma
, Francois du Plessis
, et al.
·
Gene Therapy
·
57
PDF
Monitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID mice
2001
·
Bart A Nijmeijer
, Paul Mollevanger
, et al.
·
Experimental Hematology
·
55
PDF
Human cytotoxic T lymphocytes specific for a single minor histocompatibility antigen HA-1 are effective against human lymphoblastic leukaemia in NOD/scid mice
2005
·
L Hambach
, B A Nijmeijer
, et al.
·
Leukemia
·
48
An animal model for human cellular immunotherapy: specific eradication of human acute lymphoblastic leukemia by cytotoxic T lymphocytes in NOD/scid mice
2002
·
Bart A. Nijmeijer
, Roel Willemze
, et al.
·
Blood
·
46
IL-7 receptor expression identifies suicide gene–modified allospecific CD8+ T cells capable of self-renewal and differentiation into antileukemia effectors
2011
·
Attilio Bondanza
, Lothar Hambach
, et al.
·
Blood
·
43
Human allo-reactive CD4+ T cells as strong mediators of anti-tumor immunity in NOD/scid mice engrafted with human acute lymphoblastic leukemia
2011
·
S Stevanović
, M Griffioen
, et al.
·
Leukemia
·
36
Enhanced Factor IX Activity following Administration of AAV5-R338L “Padua” Factor IX versus AAV5 WT Human Factor IX in NHPs
2019
·
Elisabeth A. Spronck
, Ying Poi Liu
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
34
PDF
The Hermansky‐Pudlak Syndrome: Evidence for a Lowered 5‐Hydroxytryptamine Content in Platelets of Heterozygotes
1977
·
S. M. Gerritsen
, J.W.N. Akkerman
, et al.
·
Scandinavian Journal of Haematology
·
33
Early Detection and Rapid Isolation of Leukemia-Reactive Donor T Cells for Adoptive Transfer Using the IFN-γ Secretion Assay
2007
·
Inge Jedema
, Pauline Meij
, et al.
·
Clinical Cancer Research
·
30
A mechanistic rationale for combining alemtuzumab and rituximab in the treatment of ALL
2010
·
Bart A. Nijmeijer
, Marianke L. J. van Schie
, et al.
·
Blood
·
27
PDF
Involvement of caspase-8 in chemotherapy-induced apoptosis of patient derived leukemia cell lines independent of the death receptor pathway and downstream from mitochondria
2006
·
J. F. de Vries
, L. J. Wammes
, et al.
·
APOPTOSIS
·
25
Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis
2022
·
Sandra Torres
, Cristina Ortiz
, et al.
·
Hepatology
·
23
First platinum(II)-based metal-organic linker technology (Lx®) for a plug-and-play development of antibody-drug conjugates (ADCs)
2019
·
Eugen Merkul
, Niels J. Sijbrandi
, et al.
·
Expert Opinion on Drug Delivery
·
22
An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the Pt II Linker Lx for Improved Manufacturability of Antibody–Drug Conjugates
2021
·
Eugen Merkul
, Joey A. Muns
, et al.
·
Angewandte Chemie International Edition
·
19
PDF
Establishment and cytogenetic characterization of a human acute lymphoblastic leukemia cell line (ALL-VG) with ETV6/ABL1 rearrangement
2008
·
Joerg Baeumler
, Karoly Szuhai
, et al.
·
Cancer Genetics and Cytogenetics
·
19
Complement-dependent cytotoxicity induced by therapeutic antibodies in B-cell acute lymphoblastic leukemia is dictated by target antigen expression levels and augmented by loss of membrane-bound complement inhibitors
2017
·
Floris C. Loeff
, H. M. Esther van Egmond
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
18
Recruitment of leukemic cells from G0 phase of the cell cycle by interferons results in conversion of resistance to daunorubicin
2003
·
I Jedema
, R M Y Barge
, et al.
·
Leukemia
·
18
The non-selective Rho-kinase inhibitors Y-27632 and Y-33075 decrease contraction but increase migration in murine and human hepatic stellate cells
2023
·
Nadine Bachtler
, Sandra Torres
, et al.
·
PLoS ONE
·
15
PDF
Combined inhibition of bile salt synthesis and intestinal uptake reduces cholestatic liver damage and colonic bile salts in mice
2023
·
Roni F. Kunst
, Isabelle Bolt
, et al.
·
JHEP Reports
·
14
PDF
Responses to donor lymphocyte infusion for acute lymphoblastic leukemia may be determined by both qualitative and quantitative limitations of antileukemic T-cell responses as observed in an animal model for human leukemia
2005
·
Bart A. Nijmeijer
, Marianke L.J. van Schie
, et al.
·
Experimental Hematology
·
14
Show more works
View as search
Works count:
58
Citation count:
1,137
H-index:
19
I10-index:
26
Year
Topic
Type